BD Announces BD Kiestra ReadA is Now Available to U.S. Clinical Microbiology Laboratories

BD Kiestra™ ReadA, Available as a Standalone Instrument, Helps Improve Operational Efficiency in Clinical Microbiology Laboratories by Automating Routine Plate Management Tasks and Delivers Accuracy Through Standardized Digital Image Acquisition

The BD Kiestra ReadA provides closed door incubation and high throughput imaging to streamline workflow, delivering high quality images for digital interpretation by laboratory staff.

By reducing the time spent sorting plates combined with high resolution imaging, the system helps enhance operational efficiency and may reduce time to result.

“Building on the landmark CE marking of BD Kiestra IdentifA in November, we continue to execute on our strategy of modular laboratory automation solutions. The BD Kiestra ReadA instrument is a first-to-market solution that will enable new customers to enter microbiology lab automation at the incubation and imaging step,” said Steve Conly, vice president of microbiology at BD. “The system transforms the manual, hands-on workflow of plate-reading to one that is automated and digital.”

Powered by BD Synapsys microbiology informatics solution, the BD Kiestra ReadA also provides on-demand patient summary overviews, allowing lab staff to access actionable information from anywhere, any time.

BD continues to invest in automation and innovation for the microbiology laboratory. For more information on BD Kiestra lab automation solutions, please visit https://www.bd.com/en-us/offerings/capabilities/lab-automation.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version